Abstract

Lamotrigine 1-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2006 - Hormone Replacement Therapy

Page(s): 223

Download in electronic PDF format for $75
  • Lamotrigine 1-mg/mL Oral Suspension Page 1

Abstract

A formulation for preparing Lamotrigine 1-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • lamotrigine
  • anticonvulsant agent
  • seizure disorders
  • bipolar disorder

Related Categories

  • FORMULATIONS
  • MENTAL HEALTH
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2006
Pg. 223
Lamotrigine 1-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 148
Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2023
Pg. 323
Lamotrigine 1 mg/mL in SuspendIt Plus
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 156
Lamotrigine 25-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 167-174
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jul/Aug 2011
Pg. 340
Methylprednisolone 4-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 486
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 502
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
May/Jun 2006
Pg. 221
Enalapril Maleate 1-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 87-89
Attention Deficit Hyperactivity Disorder
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 342
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Author(s): Allen Loyd V Jr